Preliminary Human Trials of F230 Tablets

Clinical trial NCT06899815 · RECRUITING

Trial details

NCT number: NCT06899815
Sponsor: Beijing Continent Pharmaceutical Co, Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Pulmonary Hypertension

Start date: 2025-05-15
Primary completion: 2026-07-01
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.